qPCR results showed that levels of chemokines (CXCL10, CCL5, IFN-β) were increased after silencing of TAZ in CALU-3, NCI-H520, and M109 at the presence of STING pathway agonist cGAMP and in SKIL-silenced NSCLC cell-derived tumor blocks (Fig. S4E–H). The gene discussed is CXCL10; the disease is non-small cell lung carcinoma.